These benefits, along with a past report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,two help the principle of targeting ACKR3 as a unique way to modulate the opioid procedure, which could open new therapeutic avenues for opioid-similar Diseases.Determined by available science the Conolidine alkaloi